Exploring HER2 Overexpression and its Significance as a Biomarker in pathologic T-stage of de novo Muscle-Invasive Bladder Cancer
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0008808
- Lead Sponsor
- GangNeung Asan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 174
Inclusion Criteria
The patients were recently diagnosed with urothelial cancer and had no history of urothelial cancer. Patients who underwent transurethral resection of bladder tumor at Gangneung Asan Hospital between January 2005 and December 2013.
Exclusion Criteria
If have a upper urinary tract cancer is diagnosed
diagnosed metastasized carcinoma
If the carcinoma is not a cancer originating in the urinary tract epithelium
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pathological T stage
- Secondary Outcome Measures
Name Time Method Prognosis (Pathologic T-stage, Survival)